A Phase 1 First-in-Human Single Ascending-dose Study With a Novel Antibody to the Human Thymic Stromal Lymphopoietin Receptor

Authors
Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2023
This article has no abstract
Epistemonikos ID: 3ec51f011753e4702c12d4208263df94e537a712
First added on: Feb 16, 2025